Keratoconus, progressive myopia, and development of cystoid macular edema are areas of major unmet medical need.  iVeena is developing two platform technologies in cornea and cataract — including topical delivery of copper and drug delivery from the lens capsule respectively.  These novel approaches provide impactful and minimally invasive solutions for patients and physicians.